Latest filing published 06 Oct 2022 for Global Blood Therapeutics, Inc..
Tricia Borga Suvari has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Global Blood Therapeutics, Inc. and CV Therapeutics Inc. The record holds 88 filings, for trades running from 3 January 2006 to 5 October 2022.
On the market, this insider has only sold: 12 sales, €1.2M in total. The rest of the record consists of 44 share grants and 31 option exercises.
On 6 October 2022 came the latest disclosure, a transaction in Global Blood Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 76 declarations